Skip to main content
. Author manuscript; available in PMC: 2022 May 13.
Published in final edited form as: J Vasc Interv Radiol. 2019 Sep 9;30(10):1593–1603.e3. doi: 10.1016/j.jvir.2019.06.020

Table 2.

Baseline Characteristics of Study Populations and Treatment Variables

First Author
(Reference)
Age, y Female,
%
Baseline
Weight, kg
Baseline
BMI
Dietary
Consideration
Cancer
Diagnosis
CT Angiography
for Vascular
Anomalies
Setting
Obesity clinical trials (n = 47 patients included in meta-analysis)
 Weiss (21) 44 ± 11 80 139 ± 20 45 ± 4.1 Intake assessment and dietician consultation None; excluded Yes Inpatient (for ≤ 48 h)
 Elens (20) 38 ± 10 87 79 ± 10 28.9 ± 2.5 No NA NA Inpatient (for ≤ 48 h)
 Pirlet (23) 48 ± 7 0 160 ± 27 52 ± 8 No None; excluded NA NA
 Bai (14) 42.8 ± 13.9 40 102 ± 16 38.12 ± 3.8 All followed by dietician None; excluded NA Inpatient (for 3 d)
 Syed (17) 41.0 ± 9.2 75 118 ± NA 42.4 ± NA All followed by dietician None; excluded Yes No hospital admission
 Kipshidze (16) 44.7 ± 7.4 20 128 ± 24 42.2 ± 6.8 NA NA NA Inpatient (for 1 d)
GI bleeding studies (not included in meta-analysis)
 Takahashi (22) 57.6 ± 12.9 44 87.9 ± 12.5 30.0 ± 4.3 NA None; excluded Some patients* NA
 Kim (15) 56.3 ± 15.6 43 93 ± NA 29.9 ± NA NA None; excluded NA Inpatient or ED
 Gunn (9) 64.6 (46–92) 37 NA 30.3 (20.3–58.9) NA Yes (11 of 19 patients) NA Inpatient

Note–Age, baseline weight, and baseline BMI are reported as mean ± SD.

BMI = body mass index; ED = emergency department; NA = not available.

*

Of the 16 patients, 14 had portal/venous phase CT, 1 had CT angiography, and 1 had non-contrast CT.

Expressed as mean (range).